Table 3.
Censored (below 0 and above 30) regression results predicting the propensity of rule adherence (i.e. the number of balls put into the blue bucket) with stepwise included control variables
| (1) | (2) | (3) | (4) | (5) | |
|---|---|---|---|---|---|
| B (P) | B (P) | B (P) | B (P) | B (P) | |
| Intercept | 22.59 (0.00) | 24.48 (0.00) | 23.84 (0.00) | 18.31 (0.00) | 18.00 (0.00) |
| Treatment1,a | −4.72 (0.08) | −5.79 (0.07) | −5.33 (0.14) | 0.57 (0.92) | 1.05 (0.84) |
| Sex2 | −6.04 (0.11) | −5.27 (0.26) | – | – | |
| Treatment × Sex | 2.67 (0.65) | 4.36 (0.51) | – | – | |
| BIS | −1.04 (0.76) | −0.54 (0.87) | −1.10 (0.75) | ||
| BAS | 4.61 (0.20) | 4.20 (0.26) | 4.04 (0.29) | ||
| PNS | 6.35 (0.02) | 6.16 (0.02) | 6.37 (0.02) | ||
| Treatment × BISa | 2.49 (0.60) | 3.15 (0.70) | 3.46 (0.67) | ||
| Treatment × BASa | −14.07 (0.02) | −12.19 (0.06) | −11.99 (0.07) | ||
| Treatment × PNSa | −9.69 (0.02) | −9.43 (0.04) | −9.00 (0.07) | ||
| STAI | −3.29 (0.23) | −3.93 (0.16) | |||
| Age | −0.46 (0.30) | −0.46 (0.32) | |||
| Contraception (Pill) | 5.49 (0.26) | 3.72 (0.58) | |||
| Contraception (Hormonal Spiral) | 5.43 (0.32) | 4.08 (0.52) | |||
| Treatment × Pill | −5.01 (0.47) | 2.64 (0.81) | |||
| Treatment × Hormonal Spiral | −8.03 (0.29) | −1.69 (0.87) | |||
| Follicular Phase | 0.64 (0.92) | ||||
| Luteal Phase | 5.63 (0.39) | ||||
| Treatment × Follicular Phase | −7.62 (0.44) | ||||
| Treatment × Luteal Phase | −12.90 (0.21) |
Note.10 = placebo, 1 = oxytocin; 20 = female, 1 = male. Contraception: all female participants indicated either to use the pill or a hormonal spiral—male participants are therefore coded as baseline.
a
FDR corrected P-value.